French pharma giant Sanofi struggling in race for Covid vaccine


Reading articles is for subscribers only. Subscribe now.

On December 11th 2020, French pharmaceutical group Sanofi and British pharma firm GSK (GlaxoSmithKline) announced that their joint development of a vaccine against Covid-19 was delayed after the first phase of clinical tests which began on September 3rd had shown “a low immune response” in the over-50 age group “likely due to an insufficient concentration of the antigen”.